TrialPanorama/Dataset huggingface dataset:
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: N/A
Brief Summary: The aim of the current study is to evaluate the effects of diets with three levels of dietary fat on weight change and related cardiometabolic risk factors in a 6-month randomized controlled-feeding trial.


Options:
A: Arm Label: low-fat diet; Type: EXPERIMENTAL; Interventions: Behavioral: low-fat diet | Arm Label: moderate-fat diet; Type: EXPERIMENTAL; Interventions: Behavioral: moderate-fat diet | Arm Label: high-fat diet; Type: EXPERIMENTAL; Interventions: Behavioral: high-fat diet | Intervention Type: BEHAVIORAL; Name: low-fat diet; Assigned to Arm(s): low-fat diet | Intervention Type: BEHAVIORAL; Name: moderate-fat diet; Assigned to Arm(s): moderate-fat diet | Intervention Type: BEHAVIORAL; Name: high-fat diet; Assigned to Arm(s): high-fat diet
B: Arm Label: High fat low carbohydrate diet; Type: EXPERIMENTAL; Interventions: Dietary Supplement: High fat low carbohydrate diet | Arm Label: Low fat high carbohydrate diet; Type: EXPERIMENTAL; Interventions: Dietary Supplement: Low fat high carbohydrate diet | Intervention Type: DIETARY_SUPPLEMENT; Name: High fat low carbohydrate diet; Assigned to Arm(s): High fat low carbohydrate diet | Intervention Type: DIETARY_SUPPLEMENT; Name: Low fat high carbohydrate diet; Assigned to Arm(s): Low fat high carbohydrate diet
C: Arm Label: DIPI: Danish national dietary guidelines; Type: ACTIVE_COMPARATOR; Interventions: Other: DIPI | Arm Label: DIPI: Specific IHD dietary guideline; Type: ACTIVE_COMPARATOR; Interventions: Other: DIPI | Arm Label: Normal dietary habits; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: DIPI; Assigned to Arm(s): DIPI: Danish national dietary guidelines, DIPI: Specific IHD dietary guideline
D: Arm Label: Walnut group; Type: ACTIVE_COMPARATOR; Interventions: Dietary Supplement: Walnuts | Arm Label: Control group; Type: ACTIVE_COMPARATOR; Interventions: Other: habitual diet | Intervention Type: DIETARY_SUPPLEMENT; Name: Walnuts; Assigned to Arm(s): Walnut group | Intervention Type: OTHER; Name: habitual diet; Assigned to Arm(s): Control group

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Efficacy and Safety of Heparin-coated Surface-treated Polyacrylonitrile Membrane Hemofilter in Critical Ill CRRT Patients Continuous Renal Replacement Therapy Patients
Brief Summary: CRRT patients are generally critical ill patients with unstable conditions, such as low blood pressure,severe SIRS,et al. Acute kidney injury(AKI)is especially prevalent,with even two or more organ failure. CRRT serves as an important supportive therapy.Continuous anticoagulation is needed to prevent treatment interruptions due to clotting of the extracorporeal circuit. Unfractionated heparin or low molecular weight heparin both increase the risk of bleeding and heparin induced thrombocytopenia in such cases.However, the problem of CRRT without anticoagulation is the early filter clotting. An alternative method is the use of heparin coated hemofilter. The AN69 ST hemofilter, a surface-treated polyacrylonitrile membrane hemofilter, allows irreversible fixing of heparin to filter membrane, is able to reduce thrombogenic properties of the membrane. In this study, we observe the efficacy and safety of heparin-coated AN69 ST hemofilter in CRRT patients, and compare to the original AN69 membrane hemofilter.


Options:
A: Arm Label: heparin; Type: ACTIVE_COMPARATOR; Interventions: Other: regional anticoagulation with citrate | Arm Label: Citrate; Type: ACTIVE_COMPARATOR; Interventions: Other: HfCitPre | Intervention Type: OTHER; Name: regional anticoagulation with citrate; Assigned to Arm(s): heparin | Intervention Type: OTHER; Name: HfCitPre; Assigned to Arm(s): Citrate
B: Arm Label: heparinized saline priming group; Type: EXPERIMENTAL; Interventions: Drug: heparinized saline priming group | Arm Label: nafamostat infusion group after heparinized saline priming; Type: ACTIVE_COMPARATOR; Interventions: Drug: nafamostat infusion after heparinized saline priming | Intervention Type: DRUG; Name: heparinized saline priming group; Assigned to Arm(s): heparinized saline priming group | Intervention Type: DRUG; Name: nafamostat infusion after heparinized saline priming; Assigned to Arm(s): nafamostat infusion group after heparinized saline priming
C: Arm Label: 1; Type: ACTIVE_COMPARATOR; Interventions: Device: Standard dose of dialysis | Arm Label: 2; Type: EXPERIMENTAL; Interventions: Device: High dose of dialysis | Intervention Type: DEVICE; Name: Standard dose of dialysis; Assigned to Arm(s): 1 | Intervention Type: DEVICE; Name: High dose of dialysis; Assigned to Arm(s): 2
D: Arm Label: AN69ST; Type: EXPERIMENTAL; Interventions: Device: AN69ST hemofilter | Arm Label: AN69; Type: ACTIVE_COMPARATOR; Interventions: Device: AN69 hemofilter | Intervention Type: DEVICE; Name: AN69ST hemofilter; Assigned to Arm(s): AN69ST | Intervention Type: DEVICE; Name: AN69 hemofilter; Assigned to Arm(s): AN69

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study To Assess the Efficacy, Safety, and Tolerability of Multiple Subcutaneous Injections of Depot Buprenorphine (RBP-6000 [100 mg and 300 mg]) Over 24 Weeks in Treatment-Seeking Subjects With Opioid Use Disorder
Brief Summary: This is a randomized, double-blind, placebo controlled, multicenter study in male and female participants who are seeking treatment for opioid use disorder.


Options:
A: Arm Label: RBP-6000 300mg/100mg; Type: EXPERIMENTAL; Interventions: Drug: SUBOXONE, Drug: RBP-6000 | Arm Label: RBP-6000 300mg/300mg; Type: EXPERIMENTAL; Interventions: Drug: SUBOXONE, Drug: RBP-6000 | Arm Label: Placebo Matching 300 mg/100 mg RBP-6000; Type: PLACEBO_COMPARATOR; Interventions: Drug: SUBOXONE, Drug: Placebo | Arm Label: Placebo Matching 300 mg RBP-6000; Type: PLACEBO_COMPARATOR; Interventions: Drug: SUBOXONE, Drug: Placebo | Intervention Type: DRUG; Name: SUBOXONE; Assigned to Arm(s): Placebo Matching 300 mg RBP-6000, Placebo Matching 300 mg/100 mg RBP-6000, RBP-6000 300mg/100mg, RBP-6000 300mg/300mg | Intervention Type: DRUG; Name: RBP-6000; Assigned to Arm(s): RBP-6000 300mg/100mg, RBP-6000 300mg/300mg | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo Matching 300 mg RBP-6000, Placebo Matching 300 mg/100 mg RBP-6000
B: Arm Label: 1-week buprenorphine taper; Type: EXPERIMENTAL; Interventions: Drug: buprenorphine taper followed by naltrexone maintenance, Behavioral: Behavioral therapy | Arm Label: 2-week buprenorphine taper; Type: EXPERIMENTAL; Interventions: Drug: buprenorphine taper followed by naltrexone maintenance, Behavioral: Behavioral therapy | Arm Label: 4-week buprenorphine taper; Type: EXPERIMENTAL; Interventions: Drug: buprenorphine taper followed by naltrexone maintenance, Behavioral: Behavioral therapy | Intervention Type: DRUG; Name: buprenorphine taper followed by naltrexone maintenance; Assigned to Arm(s): 1-week buprenorphine taper, 2-week buprenorphine taper, 4-week buprenorphine taper | Intervention Type: BEHAVIORAL; Name: Behavioral therapy; Assigned to Arm(s): 1-week buprenorphine taper, 2-week buprenorphine taper, 4-week buprenorphine taper
C: Intervention Type: DRUG; Name: Buprenorphine/naloxone; Assigned to Arm(s): N/A
D: Arm Label: Methadone; Type: ACTIVE_COMPARATOR; Interventions: Drug: Methadone | Arm Label: Buprenorphine/naloxone; Type: EXPERIMENTAL; Interventions: Drug: Buprenorphine/naloxone | Intervention Type: DRUG; Name: Methadone; Assigned to Arm(s): Methadone | Intervention Type: DRUG; Name: Buprenorphine/naloxone; Assigned to Arm(s): Buprenorphine/naloxone

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Collaborative Connected Health (CCH): A Pragmatic Trial Evaluating Effectiveness of CCH in Psoriasis Management Compared to In-person Visits.
Brief Summary: The investigators propose to evaluate whether an innovative collaborative connected health (CCH) model increases access to specialists and improves patient outcomes. CCH offers multiple modalities for patients and primary care providers (PCPs) to access dermatologists online directly and asynchronously to maximize effectiveness in a real-world setting. CCH also fosters team care and patient engagement through active sharing of management plans and multidirectional, informed communication among patients, PCPs, and dermatologists. The specific aims of the proposal are to (1) determine whether the CCH model results in equivalent improvements in psoriasis disease severity compared to in-person care, (2) determine whether the CCH model results in equivalent improvements in quality of life and mental health compared to in-person care, and (3) assess whether the CCH model provides better access to care than in-person care.


Options:
A: Intervention Type: DEVICE; Name: online health information journal; Assigned to Arm(s): N/A
B: Arm Label: Control; Type: OTHER; Interventions: Other: Control | Arm Label: CCH Model; Type: EXPERIMENTAL; Interventions: Other: Collaborative Connected health, (CCH) | Intervention Type: OTHER; Name: Collaborative Connected health, (CCH); Assigned to Arm(s): CCH Model | Intervention Type: OTHER; Name: Control; Assigned to Arm(s): Control
C: Arm Label: OPPC service; Type: EXPERIMENTAL; Interventions: Behavioral: OPPC service | Arm Label: WebChoice IHCA; Type: EXPERIMENTAL; Interventions: Behavioral: WebChoice IHCA | Arm Label: Control group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: OPPC service; Assigned to Arm(s): OPPC service | Intervention Type: BEHAVIORAL; Name: WebChoice IHCA; Assigned to Arm(s): WebChoice IHCA
D: Arm Label: Mobile application user group; Type: EXPERIMENTAL; Interventions: Behavioral: Daily health-related lifestyle modification prescription | Arm Label: Control group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Daily health-related lifestyle modification prescription; Assigned to Arm(s): Mobile application user group

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: HIV & Drug Abuse Prevention for South African Men
Brief Summary: The purpose of this study is to test the efficacy of randomizing all young men in a neighborhood to receive: 1) soccer training; 2) soccer and vocational training; or 3) a control condition, as a means to engage young men in HIV prevention. The investigators hypothesize that the intervention will reduce young men's substance use and increase HIV testing.


Options:
A: Arm Label: Family intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Family intervention | Arm Label: Waitlist control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Family intervention; Assigned to Arm(s): Family intervention
B: Arm Label: 1; Type: ACTIVE_COMPARATOR; Interventions: Drug: ARV treatment | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: ARV peer adherence support (PAS), Drug: ARV treatment | Arm Label: 3; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: ARV peer adherence support (PAS), Dietary Supplement: Nutritional support, Drug: ARV treatment | Arm Label: 4; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: ARV peer adherence support (PAS); Assigned to Arm(s): 2, 3 | Intervention Type: DIETARY_SUPPLEMENT; Name: Nutritional support; Assigned to Arm(s): 3 | Intervention Type: DRUG; Name: ARV treatment; Assigned to Arm(s): 1, 2, 3
C: Arm Label: Enhanced Usual Care (EUC); Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Family Networks program; Type: EXPERIMENTAL; Interventions: Behavioral: Family networks program | Intervention Type: BEHAVIORAL; Name: Family networks program; Assigned to Arm(s): Family Networks program
D: Arm Label: Soccer League (SL); Type: EXPERIMENTAL; Interventions: Behavioral: Soccer League (SL) | Arm Label: Soccer League/Vocational Training (SL-V); Type: EXPERIMENTAL; Interventions: Behavioral: Soccer League/Vocational Training (SL-V) | Arm Label: Control Condition (CC); Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Soccer League (SL); Assigned to Arm(s): Soccer League (SL) | Intervention Type: BEHAVIORAL; Name: Soccer League/Vocational Training (SL-V); Assigned to Arm(s): Soccer League/Vocational Training (SL-V)

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: The "Peripheral Access Utilizing Sonographic Evaluation" Study
Brief Summary: The purpose of this study is to reduce, by using the ultrasound guided technique, the minor surgical procedures that might be required to deliver fluids into the blood of critically ill patients simply because the patients' veins cannot be located through the manual technique.


Options:
A: Arm Label: echo guidance; Type: EXPERIMENTAL; Interventions: Device: ultrasound guidance and therapeutic communication | Arm Label: conventional; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DEVICE; Name: ultrasound guidance and therapeutic communication; Assigned to Arm(s): echo guidance
B: Arm Label: Landmark Technique Attempt; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Traditional Landmark Technique (TLT) | Arm Label: USGPIVA Technique Attempt; Type: EXPERIMENTAL; Interventions: Device: ultrasound guided peripheral intravenous access (USGPIVA) | Intervention Type: PROCEDURE; Name: Traditional Landmark Technique (TLT); Assigned to Arm(s): Landmark Technique Attempt | Intervention Type: DEVICE; Name: ultrasound guided peripheral intravenous access (USGPIVA); Assigned to Arm(s): USGPIVA Technique Attempt
C: Arm Label: Midline; Type: ACTIVE_COMPARATOR; Interventions: Device: Midline | Arm Label: Conventional; Type: ACTIVE_COMPARATOR; Interventions: Device: PVC and/or PICCline | Intervention Type: DEVICE; Name: PVC and/or PICCline; Assigned to Arm(s): Conventional | Intervention Type: DEVICE; Name: Midline; Assigned to Arm(s): Midline
D: Arm Label: Midline Catheter; Type: EXPERIMENTAL; Interventions: Device: Midline insertion | Arm Label: Peripheral intravenous cannulation (PIVC); Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DEVICE; Name: Midline insertion; Assigned to Arm(s): Midline Catheter

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: The "Peripheral Access Utilizing Sonographic Evaluation" Study
Brief Summary: The purpose of this study is to reduce, by using the ultrasound guided technique, the minor surgical procedures that might be required to deliver fluids into the blood of critically ill patients simply because the patients' veins cannot be located through the manual technique.


Options:
A: Arm Label: Landmark Technique Attempt; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Traditional Landmark Technique (TLT) | Arm Label: USGPIVA Technique Attempt; Type: EXPERIMENTAL; Interventions: Device: ultrasound guided peripheral intravenous access (USGPIVA) | Intervention Type: PROCEDURE; Name: Traditional Landmark Technique (TLT); Assigned to Arm(s): Landmark Technique Attempt | Intervention Type: DEVICE; Name: ultrasound guided peripheral intravenous access (USGPIVA); Assigned to Arm(s): USGPIVA Technique Attempt
B: Arm Label: Long Axis approach; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Intravenous access method | Arm Label: Short axis approach; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Intravenous access method | Intervention Type: PROCEDURE; Name: Intravenous access method; Assigned to Arm(s): Long Axis approach, Short axis approach
C: Arm Label: Ultrasound guided cannulation; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Peripheral vein cannulation | Arm Label: Cannulation without ultrasound; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Cannulation without ultrasound | Intervention Type: PROCEDURE; Name: Peripheral vein cannulation; Assigned to Arm(s): Ultrasound guided cannulation | Intervention Type: PROCEDURE; Name: Cannulation without ultrasound; Assigned to Arm(s): Cannulation without ultrasound
D: Arm Label: Midline; Type: ACTIVE_COMPARATOR; Interventions: Device: Midline | Arm Label: Conventional; Type: ACTIVE_COMPARATOR; Interventions: Device: PVC and/or PICCline | Intervention Type: DEVICE; Name: PVC and/or PICCline; Assigned to Arm(s): Conventional | Intervention Type: DEVICE; Name: Midline; Assigned to Arm(s): Midline

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Stay Strong: A Physical Activity Program for Afghanistan and Iraq Veterans
Brief Summary: This project is Project three of a four project Prevention Coaching Lab CREATE grant entitled "Transforming Prevention into Action" aimed at effectively engaging patients and their families to improve their health and medical care.

This project will test the feasibility and effectiveness of the prevention focused, internet mediated healthy lifestyle Stay Strong program tailored to the needs, preferences and demographics of OEF/OIF/OND Veterans.


Options:
A: Arm Label: Usual care; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Automated messages, Behavioral: Home BP monitors, Behavioral: Care partner reminders | Intervention Type: BEHAVIORAL; Name: Automated messages; Assigned to Arm(s): Intervention | Intervention Type: BEHAVIORAL; Name: Home BP monitors; Assigned to Arm(s): Intervention | Intervention Type: BEHAVIORAL; Name: Care partner reminders; Assigned to Arm(s): Intervention
B: Arm Label: Intervention to Patients; Type: EXPERIMENTAL; Interventions: Behavioral: Intervention to patients, Other: Usual care | Arm Label: Intervention to healthcare Professionals; Type: EXPERIMENTAL; Interventions: Behavioral: Intervention to professionals, Other: Usual care | Arm Label: Mixed Intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Intervention to patients, Behavioral: Intervention to professionals, Other: Usual care | Arm Label: Control; Type: OTHER; Interventions: Other: Usual care | Intervention Type: BEHAVIORAL; Name: Intervention to patients; Assigned to Arm(s): Intervention to Patients, Mixed Intervention | Intervention Type: BEHAVIORAL; Name: Intervention to professionals; Assigned to Arm(s): Intervention to healthcare Professionals, Mixed Intervention | Intervention Type: OTHER; Name: Usual care; Assigned to Arm(s): Control, Intervention to Patients, Intervention to healthcare Professionals, Mixed Intervention
C: Arm Label: Stay Strong w/coaching; Type: EXPERIMENTAL; Interventions: Behavioral: Stay Strong w/coaching | Arm Label: Stay Strong; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Stay Strong | Intervention Type: BEHAVIORAL; Name: Stay Strong w/coaching; Assigned to Arm(s): Stay Strong w/coaching | Intervention Type: BEHAVIORAL; Name: Stay Strong; Assigned to Arm(s): Stay Strong
D: Arm Label: Usual Care; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Generic Nudge; Type: EXPERIMENTAL; Interventions: Behavioral: Nudge | Arm Label: Optimized nudge; Type: EXPERIMENTAL; Interventions: Behavioral: Nudge | Arm Label: Optimized nudge plus AI Chat Bot; Type: EXPERIMENTAL; Interventions: Behavioral: Nudge | Intervention Type: BEHAVIORAL; Name: Nudge; Assigned to Arm(s): Generic Nudge, Optimized nudge, Optimized nudge plus AI Chat Bot

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Promoting Adolescent Health Through Personalized Feedback
Brief Summary: The proposed study is a randomized controlled trial that compares the effectiveness of an electronic personalized health screening app incorporating motivational feedback (i.e., "Check Yourself") to usual care. The purpose of this study is to determine whether Check Yourself is more effective than usual care in reducing health risk behaviors and improving quality of care among adolescents receiving primary health care services.


Options:
A: Arm Label: Check Yourself App With Feedback; Type: EXPERIMENTAL; Interventions: Behavioral: Check Yourself App with Feedback | Arm Label: Usual Care; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Check Yourself App with Feedback; Assigned to Arm(s): Check Yourself App With Feedback
B: Arm Label: Electronic Symptom Survey; Type: EXPERIMENTAL; Interventions: Other: Electronic symptom survey | Arm Label: Blinded Electronic Symptom Survey; Type: ACTIVE_COMPARATOR; Interventions: Other: Blinded Electronic Symptom Survey | Intervention Type: OTHER; Name: Electronic symptom survey; Assigned to Arm(s): Electronic Symptom Survey | Intervention Type: OTHER; Name: Blinded Electronic Symptom Survey; Assigned to Arm(s): Blinded Electronic Symptom Survey
C: Arm Label: Intervention group; Type: EXPERIMENTAL; Interventions: Other: AEP score available to the treating physician | Arm Label: Control group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: AEP score available to the treating physician; Assigned to Arm(s): Intervention group
D: Arm Label: Usual Care; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: THRIVE App; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: THRIVE App | Arm Label: THRIVE App+Feedback; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: THRIVE App, Behavioral: Tailored Feedback Messages | Intervention Type: BEHAVIORAL; Name: THRIVE App; Assigned to Arm(s): THRIVE App, THRIVE App+Feedback | Intervention Type: BEHAVIORAL; Name: Tailored Feedback Messages; Assigned to Arm(s): THRIVE App+Feedback

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Advancing Tobacco Use Treatment for African American Smokers
Brief Summary: The purpose of this study is to examine whether or not providing Chantix (varenicline) will help African American smokers quit smoking.


Options:
A: Arm Label: Chantix (varenicline); Type: EXPERIMENTAL; Interventions: Drug: Chantix | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Chantix; Assigned to Arm(s): Chantix (varenicline) | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo
B: Arm Label: Varenicline pre-treatmemt; Type: EXPERIMENTAL; Interventions: Drug: Varenicline | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Varenicline, Drug: Placebo | Intervention Type: DRUG; Name: Varenicline; Assigned to Arm(s): Placebo, Varenicline pre-treatmemt | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo
C: Arm Label: African American (AA) Smokers; Type: EXPERIMENTAL; Interventions: Drug: Varenicline | Arm Label: White Smokers; Type: ACTIVE_COMPARATOR; Interventions: Drug: Varenicline | Intervention Type: DRUG; Name: Varenicline; Assigned to Arm(s): African American (AA) Smokers, White Smokers
D: Arm Label: Bupropion; Type: EXPERIMENTAL; Interventions: Drug: Bupropion, Behavioral: Smoking Cessation Counseling | Arm Label: Varenicline; Type: EXPERIMENTAL; Interventions: Drug: Varenicline, Behavioral: Smoking Cessation Counseling | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo, Behavioral: Smoking Cessation Counseling | Intervention Type: DRUG; Name: Bupropion; Assigned to Arm(s): Bupropion | Intervention Type: DRUG; Name: Varenicline; Assigned to Arm(s): Varenicline | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo | Intervention Type: BEHAVIORAL; Name: Smoking Cessation Counseling; Assigned to Arm(s): Bupropion, Placebo, Varenicline

Answer: A